News

Latest news

3rd October 2022

論文掲載のお知らせ：世界初となる”U-to-C”の遺伝子編集をヒト細胞で実現しました

Read more
30th September 2022

EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells

Read more
29th September 2022

Philippe De Backer joins Newton Biocapital as a Senior Partner

Read more
15th September 2022

Sequana Medical announces H1 2022 results and provides business update

Read more
13th September 2022

SYNERGIA MEDICAL SUCCESSFULLY RAISES SERIES B FUNDING OF €9 MILLION

Read more
29th August 2022

Alexandra Clyde appointed to Sequana Medical Board of Directors

Read more
22nd July 2022

Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke

Read more
20th July 2022

Doug Kohrs appointed to Sequana Medical Board of Directors

Read more
19th July 2022

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Read more